187 related articles for article (PubMed ID: 18777001)
1. Percutaneous septal ablation after unsuccessful surgical myectomy for patients with hypertrophic obstructive cardiomyopathy.
Faber L; Welge D; Hering D; Butz T; Oldenburg O; Seggewiss H; Horstkotte D
Clin Res Cardiol; 2008 Dec; 97(12):899-904. PubMed ID: 18777001
[TBL] [Abstract][Full Text] [Related]
2. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
3. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Int J Cardiol; 2007 Jul; 119(2):163-7. PubMed ID: 17067708
[TBL] [Abstract][Full Text] [Related]
5. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
6. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
Faber L; Seggewiss H; Welge D; Fassbender D; Schmidt HK; Gleichmann U; Horstkotte D
Eur J Echocardiogr; 2004 Oct; 5(5):347-55. PubMed ID: 15341870
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
[TBL] [Abstract][Full Text] [Related]
8. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy through non-left anterior descending septal perforators.
Imori Y; Takano H; Kitamura M; Aoyama R; Sangen H; Kenta O; Matsuda J; Kubota Y; Tokita Y; Yamamoto T; Asai K; Takayama M; Shimizu W
Heart Vessels; 2020 May; 35(5):647-654. PubMed ID: 31641886
[TBL] [Abstract][Full Text] [Related]
10. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
[TBL] [Abstract][Full Text] [Related]
11. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions.
Qin JX; Shiota T; Lever HM; Asher CR; Popović ZB; Greenberg NL; Agler DA; Drinko JK; Smedira NG; Tuzcu EM; Lytle BW; Thomas JD
Am J Cardiol; 2004 Jan; 93(2):171-5. PubMed ID: 14715342
[TBL] [Abstract][Full Text] [Related]
12. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
Zeng Z; Wang F; Dou X; Zhang S; Pu J
Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
[TBL] [Abstract][Full Text] [Related]
13. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
[TBL] [Abstract][Full Text] [Related]
16. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
[TBL] [Abstract][Full Text] [Related]
17. [Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy].
Faber L; Seggewiss H; Welge D; Fassbender D; Ziemssen P; Schmidt HK; Gleichmann U; Horstkotte D
Z Kardiol; 2003 Jan; 92(1):39-47. PubMed ID: 12545300
[TBL] [Abstract][Full Text] [Related]
18. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score.
Ralph-Edwards A; Woo A; McCrindle BW; Shapero JL; Schwartz L; Rakowski H; Wigle ED; Williams WG
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):351-8. PubMed ID: 15678046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
